We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $38.6B
1-Year Est. Return 45.89%
This Fund
S&P 500
This Quarter Est. Return
+21.98%
1 Year Est. Return
+45.89%
3 Year Est. Return
+130.56%
5 Year Est. Return
+159.19%
10 Year Est. Return
+649.1%
AUM
$99.7B
AUM Growth
-$35.3B
Cap. Flow
-$51.2B
Cap. Flow %
-51.39%
Top 10 Hldgs %
38.1%
Holding
3,429
New
429
Increased
712
Reduced
935
Closed
1,256

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.57%
2 Technology 1.47%
3 Communication Services 0.76%
4 Financials 0.54%
5 Industrials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DISCK
3301
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-600
Closed -$12K
HMHC
3302
CALL
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-50,000
Closed -$87K
HMHC
3303
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-69,905
Closed -$121K
PVG
3304
PUT
DELISTED
PRETIUM RESOURCES INC.
PVG
-400
Closed -$5K
BTAQU
3305
DELISTED
Burgundy Technology Acquisition Corporation Unit
BTAQU
-30,000
Closed -$299K
RDS.B
3306
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-1,207
Closed -$35.9K
CFXA
3307
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
-654,019
Closed -$87.8M
ATH
3308
CALL
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
-95,000
Closed -$3.24M
ATH
3309
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
-2,255
Closed -$77K
ATH
3310
PUT
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
-43,100
Closed -$1.47M
DRNA
3311
CALL
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-126,600
Closed -$2.28M
DRNA
3312
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-18,388
Closed -$331K
BSN.U
3313
DELISTED
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
-30,000
Closed -$299K
KSU
3314
CALL
DELISTED
Kansas City Southern
KSU
-3,500
Closed -$632K
PPD
3315
CALL
DELISTED
PPD, Inc. Common Stock
PPD
-60,000
Closed -$2.22M
PPD
3316
DELISTED
PPD, Inc. Common Stock
PPD
-13,531
Closed -$501K
XLRN
3317
CALL
DELISTED
Acceleron Pharma
XLRN
-46,300
Closed -$5.21M
XLRN
3318
DELISTED
Acceleron Pharma
XLRN
-11,391
Closed -$1.28M
CSOD
3319
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
-170,300
Closed -$6.19M
CSOD
3320
DELISTED
Cornerstone OnDemand, Inc.
CSOD
-59,327
Closed -$2.16M
STWOU
3321
DELISTED
ACON S2 Acquisition Corp Unit
STWOU
-29,650
Closed -$297K
CLDR
3322
CALL
DELISTED
Cloudera, Inc.
CLDR
-12,100
Closed -$130K
CLDR
3323
DELISTED
Cloudera, Inc.
CLDR
-18,202
Closed -$198K
CLDR
3324
PUT
DELISTED
Cloudera, Inc.
CLDR
-507,600
Closed -$5.53M
QELLU
3325
DELISTED
Qell Acquisition Corp. Unit
QELLU
-65,000
Closed -$660K

Similar funds

Parallax Volatility Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Parallax Volatility Advisers held 3,429 positions worth $99.7B, down 26% from $135B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Parallax Volatility Advisers withdrew a net $51.2B in Q4 2020, closing 1,256 positions and reducing 935 holdings. Its most notable exit was Adobe, an estimated $209M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.6% of assets, up from 1.1% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Parallax Volatility Advisers opened a new position in Insulet worth $12.8M.

  • Parallax Volatility Advisers's largest Q4 2020 buy was Insulet: 50,183 shares worth $12.8M.
  • Parallax Volatility Advisers added most to Tesla in Q4 2020, an estimated $336M increase.
  • Parallax Volatility Advisers's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $471M.
  • Parallax Volatility Advisers fully exited Adobe in Q4 2020, selling an estimated $209M.
  • Parallax Volatility Advisers's ten largest holdings make up 38% of its $99.7B portfolio in Q4 2020.
  • Parallax Volatility Advisers opened 429 new positions and closed 1,256 in Q4 2020.
  • Parallax Volatility Advisers's portfolio value fell 26% quarter-over-quarter to $99.7B.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.